AI-Driven Treatment Strategy vs ZR2 in Older Treatment-naive Patients With LBCL

Clinical trial NCT07717177 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07717177
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Large B-Cell Lymphoma (LBCL)

Start date: 2026-06-30
Primary completion: 2029-06-30
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.